Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2025 Earnings Call Highlights: Strong Growth in India and Brazil Amid Operational Challenges
Torrent Pharmaceuticals Ltd (BOM:500420) reports a 9% revenue increase, driven by robust performance in branded businesses and strategic market expansion. Oct 28, 2024
Drug Manufacturers
Sanofi SA (SNY) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Advances
Sanofi SA (SNY) reports a robust 16% sales increase, driven by Dupixent and vaccines, while navigating market challenges and strategic divestments. Oct 26, 2024
Drug Manufacturers
Aarti Drugs Ltd (BOM:524348) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives
Aarti Drugs Ltd (BOM:524348) reports mixed results with promising growth in API volumes and strategic investments amid market challenges. Oct 26, 2024
Muslim Farooque Drug Manufacturers Eli Lilly's Ebglyss Emerges as New Option for Patients Struggling with Dupixent Treatment
Ebglyss proves effective in relieving dermatitis symptoms, showing promise as a substitute for Dupixent in challenging cases Oct 25, 2024
Khac Phu Nguyen Drug Manufacturers Sanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment Plans
Record-breaking growth and strategic shifts propel Sanofi to new heights--here's what investors need to know Oct 25, 2024
Drug Manufacturers
Indoco Remedies Ltd (BOM:532612) Q2 2025 Earnings Call Highlights: Navigating Challenges and Celebrating Milestones
Despite facing international revenue declines, Indoco Remedies Ltd (BOM:532612) marks 77 years of excellence and expands its product portfolio. Oct 25, 2024
Drug Manufacturers
Sanofi (SNY): Strong Q3 Earnings Driven by Vaccine Demand and Dupixent Sales
Oct 25, 2024
Drug Manufacturers
Swedish Orphan Biovitrum AB (BIOVF) Q3 2024 Earnings Call Highlights: Robust Growth and Strategic Advancements
Swedish Orphan Biovitrum AB (BIOVF) reports impressive revenue growth and strategic progress, despite facing market challenges and competitive pressures. Oct 25, 2024
Drug Manufacturers
Genomma Lab Internacional SAB de CV (GNMLF) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic Growth Initiatives
Genomma Lab Internacional SAB de CV (GNMLF) reports robust revenue growth, improved margins, and strategic expansions despite regional challenges. Oct 25, 2024
Drug Manufacturers
Laurus Labs Ltd (BOM:540222) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives
Laurus Labs Ltd (BOM:540222) maintains strong gross margins and anticipates growth in its CDMO division despite facing revenue declines in key segments. Oct 25, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers